About this trial
The purpose of this pilot study is to investigate the phenotype, anti-tumor effector functions, and TCR repertoire of T cells isolated from patient tumor draining lymph nodes (TDLNs) to understand T cell priming and trafficking patterns in Renal Cell Carcinoma (RCC). Data and biospecimen collected will be used for current and future research projects involving the study of kidney cancer biology and related medical conditions. Investigators will use this valuable resource to ask clinically relevant translational questions that pertain to biomarker discovery/validation, identification of novel therapeutic targets, and to better understand the genetic and biological basis of the various kidney cancers.
Eligibility criteria
Qualifiers
None
Disqualifiers
Participants under the age of 18. Children will not be enrolled on the study.
Participants known to be pregnant or actively breastfeeding.
Iodine allergy hypersensitivity.
Trial design
Treatments tested in this trial
- Peripheral Blood Sample for Immune Analysis
- Tumor Sample for Analysis
- Adjacent non-malignant kidney for analysis
- Draining lymph node(s) for analysis
- Regional non-draining lymph node(s) for analysis